KemPharm Story
| KMPHDelisted Stock | USD 5.81 0.02 0.34% |
Under 61% of KemPharm's investor base is looking to short. The analysis of current outlook of investing in KemPharm suggests that many traders are alarmed regarding KemPharm's prospects. KemPharm's investor sentiment overview provides quick insight into current market opportunities from investing in KemPharm. The current market sentiment, together with KemPharm's historical and current headlines, can help investors time the market. In addition, many technical investors use KemPharm stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
KemPharm stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of KemPharm daily returns and investor perception about the current price of KemPharm as well as its diversification or hedging effects on your existing portfolios.
KemPharm |
Requested story not found. it has been either deleted or moved. View all stories for KemPharm.
KemPharm Latest Timeline
KemPharm is listed for 5.81. About 18.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.69. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. KemPharm recorded a loss per share of 0.91. The entity last dividend was issued on the 28th of December 2020. The firm had 1:16 split on the 28th of December 2020.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in KemPharm Stock
If you are still planning to invest in KemPharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the KemPharm's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |